 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
1apw
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.23.20
- Penicillopepsin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of proteins with broad specificity similar to that of pepsin A, preferring hydrophobic residues at P1 and P1', but also cleaving 20-Gly-|-Glu-21 in the B chain of insulin. Clots milk, and activates trypsinogen.
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
proteolysis
|
1 term
|
 |
|
Biochemical function
|
hydrolase activity
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
31:3872-3886
(1992)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides.
|
|
M.N.James,
A.R.Sielecki,
K.Hayakawa,
M.H.Gelb.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Difluorostatine- and difluorostatone-containing peptides have been evaluated as
potent inhibitors of penicillopepsin, a member of the aspartic proteinase family
of enzymes. Isovaleryl-Val-Val-StaF2NHCH3 [StaF2 =
(S)-4-amino-2,2-difluoro-(R)-3-hydroxy-6-methylheptanoic acid] and
isovaleryl-Val-Val-StoF2NHCH3 [StoF2 =
(S)-4-amino-2,2-difluoro-3-oxo-6-methylheptanoic acid] have measured Ki's of 10
x 10(-9) and 1 x 10(-9) M, respectively, with this fungal proteinase. The
StoF2-containing peptide binds 32-fold more tightly to the enzyme than the
analogous peptide containing the non-fluorinated statine ethyl ester. Each
compound was cocrystallized with penicillopepsin, intensity data were collected
to 1.8-A resolution, and the atomic coordinates were refined to an R factor
[formula: see text] of 0.131 for both complexes. The inhibitors bind in the
active site of penicillopepsin in much the same fashion as do other
statine-containing inhibitors of penicillopepsin analyzed earlier [James, M. N.
G., Sielecki, A. Salituro, F., Rich, D. H., & Hofmann, T. (1982) Proc. Natl.
Acad. Sci. U.S.A. 79, 6137-6141; James, M.N.G., Sielecki, A., & Hofmann, T.
(1985) in Aspartic Proteinases and their Inhibitors (Kosta, V., Ed.) pp 163-177,
Walter deGruyter, Berlin]. The (R)-3-hydroxyl group in StaF2 binds between the
active site carboxyl groups of Asp33 and Asp213, making hydrogen-bonding
contacts to each one. The ketone functional group of the StoF2 inhibitor is
bound as a hydrated species, with the gem-diol situated between the two aspartic
acid carboxyl groups in a manner similar to that predicted for the tetrahedral
intermediate expected during the catalytic hydrolysis of a peptide bond [James,
M. N. G., & Sielecki, A. (1985) Biochemistry 24, 3701-3713]. One
hydrogen-bonding interaction from the "outer" hydroxyl group is made
to O delta 1 of Asp33, and the "inner" hydroxyl group forms two
hydrogen-bonding contacts, one to each of the carboxyl groups of Asp33 (O delta
2) and Asp213 (O delta 2). The only structural difference between the StaF2 and
StoF2 inhibitors that accounts for the factor of 10 in their Ki's is the
additional (R)-3-OH group on the tetrahedral sp3 carbon atom of the hydrated
StoF2 inhibitor. The intermolecular interactions involving the fluorine atoms of
each inhibitor are normal van der Waals contacts to one of the carboxyl oxygen
atoms of Asp213 (F2-O delta 2 Asp213, 2.9 A). The observed stereochemistry of
the bound StoF2 group in the active site of penicillopepsin has stimulated our
reappraisal of the catalytic pathway for the aspartic proteinases.(ABSTRACT
TRUNCATED AT 400 WORDS)
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Fäh,
L.A.Hardegger,
L.Baitsch,
W.B.Schweizer,
S.Meyer,
D.Bur,
and
F.Diederich
(2009).
New organofluorine building blocks: inhibition of the malarial aspartic proteases plasmepsin II and IV by alicyclic alpha,alpha-difluoroketone hydrates.
|
| |
Org Biomol Chem, 7,
3947-3957.
|
 |
|
|
|
|
 |
V.Prashar,
S.Bihani,
A.Das,
J.L.Ferrer,
and
M.Hosur
(2009).
Catalytic water co-existing with a product peptide in the active site of HIV-1 protease revealed by X-ray structure analysis.
|
| |
PLoS One, 4,
e7860.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Borelli,
E.Ruge,
J.H.Lee,
M.Schaller,
A.Vogelsang,
M.Monod,
H.C.Korting,
R.Huber,
and
K.Maskos
(2008).
X-ray structures of Sap1 and Sap5: structural comparison of the secreted aspartic proteinases from Candida albicans.
|
| |
Proteins, 72,
1308-1319.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Coates,
H.F.Tuan,
S.Tomanicek,
A.Kovalevsky,
M.Mustyakimov,
P.Erskine,
and
J.Cooper
(2008).
The catalytic mechanism of an aspartic proteinase explored with neutron and X-ray diffraction.
|
| |
J Am Chem Soc, 130,
7235-7237.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.F.Tuan,
P.Erskine,
P.Langan,
J.Cooper,
and
L.Coates
(2007).
Preliminary neutron and ultrahigh-resolution X-ray diffraction studies of the aspartic proteinase endothiapepsin cocrystallized with a gem-diol inhibitor.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 63,
1080-1083.
|
 |
|
|
|
|
 |
L.Coates,
P.T.Erskine,
S.Mall,
R.Gill,
S.P.Wood,
D.A.Myles,
and
J.B.Cooper
(2006).
X-ray, neutron and NMR studies of the catalytic mechanism of aspartic proteinases.
|
| |
Eur Biophys J, 35,
559-566.
|
 |
|
|
|
|
 |
M.N.James
(2006).
The peptidases from fungi and viruses.
|
| |
Biol Chem, 387,
1023-1029.
|
 |
|
|
|
|
 |
A.Onoda,
H.Yamamoto,
Y.Yamada,
K.Lee,
S.Adachi,
T.A.Okamura,
K.Yoshizawa-Kumagaye,
K.Nakajima,
T.Kawakami,
S.Aimoto,
and
N.Ueyama
(2005).
Switching of turn conformation in an aspartate anion peptide fragment by NH . . . O- hydrogen bonds.
|
| |
Biopolymers, 80,
233-248.
|
 |
|
|
|
|
 |
D.Kovalskyy,
V.Dubyna,
A.E.Mark,
and
A.Kornelyuk
(2005).
A molecular dynamics study of the structural stability of HIV-1 protease under physiological conditions: the role of Na+ ions in stabilizing the active site.
|
| |
Proteins, 58,
450-458.
|
 |
|
|
|
|
 |
R.Paulini,
K.Müller,
and
F.Diederich
(2005).
Orthogonal multipolar interactions in structural chemistry and biology.
|
| |
Angew Chem Int Ed Engl, 44,
1788-1805.
|
 |
|
|
|
|
 |
M.Fujinaga,
M.M.Cherney,
H.Oyama,
K.Oda,
and
M.N.James
(2004).
The molecular structure and catalytic mechanism of a novel carboxyl peptidase from Scytalidium lignicolum.
|
| |
Proc Natl Acad Sci U S A, 101,
3364-3369.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Dash,
S.Phadtare,
V.Deshpande,
and
M.Rao
(2001).
Structural and mechanistic insight into the inhibition of aspartic proteases by a slow-tight binding inhibitor from an extremophilic Bacillus sp.: correlation of the kinetic parameters with the inhibitor induced conformational changes.
|
| |
Biochemistry, 40,
11525-11532.
|
 |
|
|
|
|
 |
N.S.Andreeva,
and
L.D.Rumsh
(2001).
Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes.
|
| |
Protein Sci, 10,
2439-2450.
|
 |
|
|
|
|
 |
M.Fujinaga,
M.M.Cherney,
N.I.Tarasova,
P.A.Bartlett,
J.E.Hanson,
and
M.N.James
(2000).
Structural study of the complex between human pepsin and a phosphorus-containing peptidic -transition-state analog.
|
| |
Acta Crystallogr D Biol Crystallogr, 56,
272-279.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Q.N.Cao,
M.Stubbs,
K.Q.Ngo,
M.Ward,
A.Cunningham,
E.F.Pai,
G.C.Tu,
and
T.Hofmann
(2000).
Penicillopepsin-JT2, a recombinant enzyme from Penicillium janthinellum and the contribution of a hydrogen bond in subsite S3 to k(cat).
|
| |
Protein Sci, 9,
991.
|
 |
|
|
|
|
 |
M.S.Wolfe,
W.Xia,
C.L.Moore,
D.D.Leatherwood,
B.Ostaszewski,
T.Rahmati,
I.O.Donkor,
and
D.J.Selkoe
(1999).
Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease.
|
| |
Biochemistry, 38,
4720-4727.
|
 |
|
|
|
|
 |
A.R.Khan,
J.C.Parrish,
M.E.Fraser,
W.W.Smith,
P.A.Bartlett,
and
M.N.James
(1998).
Lowering the entropic barrier for binding conformationally flexible inhibitors to enzymes.
|
| |
Biochemistry, 37,
16839-16845.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.R.Khan,
and
M.N.James
(1998).
Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.
|
| |
Protein Sci, 7,
815-836.
|
 |
|
|
|
|
 |
M.B.Rao,
A.M.Tanksale,
M.S.Ghatge,
and
V.V.Deshpande
(1998).
Molecular and biotechnological aspects of microbial proteases.
|
| |
Microbiol Mol Biol Rev, 62,
597-635.
|
 |
|
|
|
|
 |
G.S.Laco,
C.Schalk-Hihi,
J.Lubkowski,
G.Morris,
A.Zdanov,
A.Olson,
J.H.Elder,
A.Wlodawer,
and
A.Gustchina
(1997).
Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor.
|
| |
Biochemistry, 36,
10696-10708.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Beveridge
(1996).
A theoretical study of torsional flexibility in the active site of aspartic proteinases: implications for catalysis.
|
| |
Proteins, 24,
322-334.
|
 |
|
|
|
|
 |
D.M.van Aalten,
R.Bywater,
J.B.Findlay,
M.Hendlich,
R.W.Hooft,
and
G.Vriend
(1996).
PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules.
|
| |
J Comput Aided Mol Des, 10,
255-262.
|
 |
|
|
|
|
 |
G.Iliadis,
B.Brzezinski,
and
G.Zundel
(1996).
Aspartic proteinases: Fourier transform infrared spectroscopic studies of a model of the active side.
|
| |
Biophys J, 71,
2840-2847.
|
 |
|
|
|
|
 |
R.B.Rose,
C.S.Craik,
N.L.Douglas,
and
R.M.Stroud
(1996).
Three-dimensional structures of HIV-1 and SIV protease product complexes.
|
| |
Biochemistry, 35,
12933-12944.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.OĆdziej,
and
J.Ciarkowski
(1996).
Mechanism of action of aspartic proteinases: application of transition-state analogue theory.
|
| |
J Comput Aided Mol Des, 10,
583-588.
|
 |
|
|
|
|
 |
D.Bailey,
and
J.B.Cooper
(1994).
A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.
|
| |
Protein Sci, 3,
2129-2143.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Baca,
and
S.B.Kent
(1993).
Catalytic contribution of flap-substrate hydrogen bonds in "HIV-1 protease" explored by chemical synthesis.
|
| |
Proc Natl Acad Sci U S A, 90,
11638-11642.
|
 |
|
|
|
|
 |
S.S.Abdel-Meguid
(1993).
Inhibitors of aspartyl proteinases.
|
| |
Med Res Rev, 13,
731-778.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|